India to United Kingdom: Naproxen Export Trade Route
India has recorded 130 verified shipments of Naproxen exported to United Kingdom, representing a combined trade value of $3.9M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $30.0K USD. The leading Indian exporter is S KANT HEALTHCARE LIMITED, which accounts for 37% of total export value with 35 shipments worth $1.5M USD. On the buying side, TO THE ORDER is the largest importer in United Kingdom with $1.0M USD in purchases. The top 3 suppliers — S KANT HEALTHCARE LIMITED, BAFNA PHARMACEUTICALS LIMITED, FOURRTS INDIA LABORATORIES PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Naproxen corridor is one of India's established pharmaceutical export routes, with 130 shipments documented worth a combined $3.9M USD. The route is dominated by S KANT HEALTHCARE LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's naproxen manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $30.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with naproxen's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 25.9%, placing it at rank #2 among India's top naproxen export destinations globally.
On the import side, key buyers of Indian naproxen in United Kingdom include TO THE ORDER, NOUMED LIFE SCIENCES LIMITED, MILPHARM LIMITED and 10 others. TO THE ORDER is the single largest importer with 28 shipments valued at $1.0M USD.
Route Characteristics
- Average transit21 days
